Literature DB >> 26557001

Colorectal cancer: Metastases to a single organ.

Sina Vatandoust1, Timothy J Price1, Christos S Karapetis1.   

Abstract

Colorectal cancer (CRC) is a common malignancy worldwide. In CRC patients, metastases are the main cause of cancer-related mortality. In a group of metastatic CRC patients, the metastases are limited to a single site (solitary organ); the liver and lungs are the most commonly involved sites. When metastatic disease is limited to the liver and/or lungs, the resectability of the metastatic lesions will dictate the management approach and the outcome. Less commonly, the site of solitary organ CRC metastasis is the peritoneum. In these patients, cytoreduction followed by hyperthermic intraperitoneal chemotherapy may improve the outcome. Rarely, CRC involves other organs, such as the brain, bone, adrenals and spleen, as the only site of metastatic disease. There are limited data to guide clinical practice in these cases. Here, we have reviewed the disease characteristics, management approaches and prognosis based on the metastatic disease site in patients with CRC with metastases to a single organ.

Entities:  

Keywords:  Bone metastasis; Brain metastasis; Colorectal cancer; Disease management; Liver metastasis; Lung metastasis; Metastasis; Peritoneal metastasis; Prognosis

Mesh:

Year:  2015        PMID: 26557001      PMCID: PMC4631975          DOI: 10.3748/wjg.v21.i41.11767

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  142 in total

1.  Recurrence after curative excision of carcinoma of the large bowel.

Authors:  E S HUGHES; A M CUTHBERTSON
Journal:  JAMA       Date:  1962-12-29       Impact factor: 56.272

2.  Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model.

Authors:  S Salah; K Watanabe; S Welter; J S Park; J W Park; J Zabaleta; F Ardissone; J Kim; M Riquet; K Nojiri; M Gisabella; S Y Kim; K Tanaka; B Al-Haj Ali
Journal:  Ann Oncol       Date:  2012-04-29       Impact factor: 32.976

3.  Management of a Solitary Bone Metastasis to the Tibia from Colorectal Cancer.

Authors:  Anastasia S Chalkidou; Anastasios L Boutis; Panagiotis Padelis
Journal:  Case Rep Gastroenterol       Date:  2009-11-21

4.  Lung recurrence after curative surgery for colorectal cancer.

Authors:  E Pihl; E S Hughes; F T McDermott; W R Johnson; H Katrivessis
Journal:  Dis Colon Rectum       Date:  1987-06       Impact factor: 4.585

Review 5.  Resection of pulmonary metastases from colorectal carcinoma.

Authors:  R Warwick; R Page
Journal:  Eur J Surg Oncol       Date:  2007-11-26       Impact factor: 4.424

6.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

7.  Unusual bony colorectal metastases in post-hepatometastasectomy patients.

Authors:  Aali J Sheen; David Drake; Stephen Langton; David J Sherlock
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

8.  Factors influencing the natural history of colorectal liver metastases.

Authors:  R Stangl; A Altendorf-Hofmann; R M Charnley; J Scheele
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

9.  Neurosurgical management and postoperative whole-brain radiotherapy for colorectal cancer patients with symptomatic brain metastases.

Authors:  Giuseppe Aprile; Elisa Zanon; Francesco Tuniz; Emiliana Iaiza; Federica De Pauli; Nicoletta Pella; Stefano Pizzolitto; Alberto Buffoli; Andrea Piga; Miran Skrap; Gianpiero Fasola
Journal:  J Cancer Res Clin Oncol       Date:  2008-09-09       Impact factor: 4.553

Review 10.  The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Steven N Kalkanis; Douglas Kondziolka; Laurie E Gaspar; Stuart H Burri; Anthony L Asher; Charles S Cobbs; Mario Ammirati; Paula D Robinson; David W Andrews; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Mark E Linskey
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

View more
  79 in total

1.  Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth.

Authors:  Sebastian Senger; Jens Sperling; Barbara Oberkircher; Martin K Schilling; Otto Kollmar; Michael D Menger; Christian Ziemann
Journal:  Clin Exp Metastasis       Date:  2017-06-19       Impact factor: 5.150

2.  Brain metastases in colorectal cancer: prognostic factors and survival analysis.

Authors:  Luis Del Carpio Huerta; Anna Cristina Virgili Manrique; Justyna Szafranska; Marta Martin-Richard; David Paez Lopez-Bravo; Ana Sebio Garcia; Iñigo Espinosa Mariscal; Paula Gomila Pons; Marta Andres Granyo; Andres Barba Joaquin; Agusti Barnadas Molins; Maria Tobeña Puyal
Journal:  Int J Colorectal Dis       Date:  2018-06-25       Impact factor: 2.571

3.  Pulmonary metastasis in newly diagnosed colon-rectal cancer: a population-based nomogram study.

Authors:  Yiwei Huang; Mengnan Zhao; Jiacheng Yin; Tao Lu; Xiaodong Yang; Guangda Yuan; Ming Li; Yu Liu; Cheng Zhan; Qun Wang
Journal:  Int J Colorectal Dis       Date:  2019-03-11       Impact factor: 2.571

4.  TRF-20-M0NK5Y93 suppresses the metastasis of colon cancer cells by impairing the epithelial-to-mesenchymal transition through targeting Claudin-1.

Authors:  Na Luan; Yiquan Chen; Qingsong Li; Yali Mu; Qin Zhou; Xun Ye; Qun Deng; Limian Ling; Jian Wang; Jianwei Wang
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

5.  Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.

Authors:  Dongjun Jeong; Hyeongjoo Kim; Seona Ban; Seunghyun Oh; Sanghee Ji; Doyeon Kim; Tae Sung Ahn; Han Jo Kim; Sang Byung Bae; Hyog Young Kwon; Jungkyun Im; Moon Soo Lee; Hyun Deuk Cho; Chang-Jin Kim; Moo-Jun Baek
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-05       Impact factor: 4.553

6.  Long non-coding RNA LINC01410 promotes colon cancer cell proliferation and invasion by inhibiting miR-3128.

Authors:  Jihui Luo; Yi Guo; Xiaofei Liu; Xihua Yang; Fangtao Xiao; Meihua Zhou
Journal:  Exp Ther Med       Date:  2018-09-28       Impact factor: 2.447

7.  Targeted Quantitative Kinome Analysis Identifies PRPS2 as a Promoter for Colorectal Cancer Metastasis.

Authors:  Weili Miao; Yinsheng Wang
Journal:  J Proteome Res       Date:  2019-04-02       Impact factor: 4.466

8.  Addition of adjuvant hepatic artery infusion to systemic chemotherapy following resection of colorectal liver metastases is associated with reduced liver-related mortality.

Authors:  Rami Srouji; Raja Narayan; Thomas Boerner; Florian Buisman; Ken Seier; Mithat Gonen; Vinod P Balachandran; Jeffrey Drebin; William R Jarnagin; T Peter Kingham; Alice Wei; Nancy E Kemeny; Michael D'Angelica
Journal:  J Surg Oncol       Date:  2020-03-31       Impact factor: 3.454

9.  Electrocoagulation for liver metastases.

Authors:  Dawid Storman; Mateusz J Swierz; Robert P Riemsma; Robert Wolff; Jerzy W Mitus; Michal Pedziwiatr; Jos Kleijnen; Malgorzata M Bala
Journal:  Cochrane Database Syst Rev       Date:  2021-01-28

10.  Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patients.

Authors:  Nan Wang; Fangqi Liu; Wenqi Xi; Jinling Jiang; Yun Xu; Bingjie Guan; Junwei Wu; Chenfei Zhou; Min Shi; Zhenggang Zhu; Ye Xu; Jing Liu; Jun Zhang
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.